Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Measuring adrenal autoantibody response: interlaboratory concordance in the first international serum exchange for the determination of 21-hydroxylase autoantibodies.

Falorni A, Chen S, Zanchetta R, Yu L, Tiberti C, Bacosi ML, Furmaniak J, Bini V, Dotta F, Eisenbarth GS, Smith BR, Betterle C.

Clin Immunol. 2011 Sep;140(3):291-9. doi: 10.1016/j.clim.2011.04.012. Epub 2011 Apr 28.

PMID:
21570358
2.

Determination of 21-hydroxylase autoantibodies: inter-laboratory concordance in the Euradrenal International Serum Exchange Program.

Falorni A, Bini V, Betterle C, Brozzetti A, Castaño L, Fichna M, Kämpe O, Mellgren G, Peterson P, Chen S, Rönnelid J, Seissler J, Tiberti C, Uibo R, Yu L, Lernmark Å, Husebye E.

Clin Chem Lab Med. 2015 Oct;53(11):1761-70. doi: 10.1515/cclm-2014-1106.

PMID:
25811668
3.

Autoantibody responses in autoimmune ovarian insufficiency and in Addison's disease are IgG1 dominated and suggest a predominant, but not exclusive, Th1 type of response.

Brozzetti A, Marzotti S, La Torre D, Bacosi ML, Morelli S, Bini V, Ambrosi B, Giordano R, Perniola R, De Bellis A, Betterle C, Falorni A; Italian Addison Network.

Eur J Endocrinol. 2010 Aug;163(2):309-17. doi: 10.1530/EJE-10-0257. Epub 2010 May 24.

4.
5.

Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison's disease.

Laureti S, De Bellis A, Muccitelli VI, Calcinaro F, Bizzarro A, Rossi R, Bellastella A, Santeusanio F, Falorni A.

J Clin Endocrinol Metab. 1998 Oct;83(10):3507-11.

PMID:
9768655
6.

21-hydroxylase autoantibody-negative Addison's disease in a 5-year-old boy with adrenal crisis and type 1 diabetes mellitus.

Chang JT, Chen YY, Chiu PC.

J Pediatr Endocrinol Metab. 2010 Nov;23(11):1201-5.

PMID:
21284337
7.

Low dose (1 microg) ACTH test in the evaluation of adrenal dysfunction in pre-clinical Addison's disease.

Laureti S, Arvat E, Candeloro P, Di Vito L, Ghigo E, Santeusanio F, Falorni A.

Clin Endocrinol (Oxf). 2000 Jul;53(1):107-15.

PMID:
10931087
8.

Italian addison network study: update of diagnostic criteria for the etiological classification of primary adrenal insufficiency.

Falorni A, Laureti S, De Bellis A, Zanchetta R, Tiberti C, Arnaldi G, Bini V, Beck-Peccoz P, Bizzarro A, Dotta F, Mantero F, Bellastella A, Betterle C, Santeusanio F; SIE Addison Study Group.

J Clin Endocrinol Metab. 2004 Apr;89(4):1598-604.

PMID:
15070918
9.

Adrenal-cortex autoantibodies and steroid-producing cells autoantibodies in patients with Addison's disease: comparison of immunofluorescence and immunoprecipitation assays.

Betterle C, Volpato M, Pedini B, Chen S, Smith BR, Furmaniak J.

J Clin Endocrinol Metab. 1999 Feb;84(2):618-22.

PMID:
10022426
10.

Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease, and premature ovarian failure.

Chen S, Sawicka J, Betterle C, Powell M, Prentice L, Volpato M, Rees Smith B, Furmaniak J.

J Clin Endocrinol Metab. 1996 May;81(5):1871-6.

PMID:
8626850
11.

A study of the epitopes on steroid 21-hydroxylase recognized by autoantibodies in patients with or without Addison's disease.

Volpato M, Prentice L, Chen S, Betterle C, Rees Smith B, Furmaniak J.

Clin Exp Immunol. 1998 Feb;111(2):422-8.

12.

Prevalence of adrenal antibodies in Addison's disease among north Indian Caucasians.

Nigam R, Bhatia E, Miao D, Yu L, Brozzetti A, Eisenbarth GS, Falorni A.

Clin Endocrinol (Oxf). 2003 Nov;59(5):593-8.

PMID:
14616882
13.

[21-hydroxylase autoantibodies as a marker of adrenal involvement in patients with autoimmune endocrinopathies].

Degros V, Pons L, Ghulam A, Racadot A.

Ann Biol Clin (Paris). 1999 Nov-Dec;57(6):705-9. French.

14.

Steroid 21-hydroxylase autoantibodies: measurements with a new immunoprecipitation assay.

Tanaka H, Perez MS, Powell M, Sanders JF, Sawicka J, Chen S, Prentice L, Asawa T, Betterle C, Volpato M, Smith BR, Furmaniak J.

J Clin Endocrinol Metab. 1997 May;82(5):1440-6.

PMID:
9141530
15.

Autoantibodies against glutamic acid decarboxylase and 21-hydroxylase in Brazilian patients with type 1 diabetes or autoimmune thyroid diseases.

Silva RC, Sallorenzo C, Kater CE, Dib SA, Falorni A.

Diabetes Nutr Metab. 2003 Jun;16(3):160-8.

PMID:
14635733
16.
17.

21-hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease. Belgian Diabetes Registry.

Falorni A, Laureti S, Nikoshkov A, Picchio ML, Hallengren B, Vandewalle CL, Gorus FK, Tortoioli C, Luthman H, Brunetti P, Santeusanio F.

Clin Exp Immunol. 1997 Feb;107(2):341-6.

18.

Autoantibodies to adrenal cytochrome P450 antigens in isolated Addison's disease and autoimmune polyendocrine syndrome type II.

Seissler J, Schott M, Steinbrenner H, Peterson P, Scherbaum WA.

Exp Clin Endocrinol Diabetes. 1999;107(3):208-13.

PMID:
10376448
19.

Time course of 21-hydroxylase antibodies and long-term remission of subclinical autoimmune adrenalitis after corticosteroid therapy: case report.

De Bellis A A, Falorni A, Laureti S, Perrino S, Coronella C, Forini F, Bizzarro E, Bizzarro A, Abbate G, Bellastella A.

J Clin Endocrinol Metab. 2001 Feb;86(2):675-8.

PMID:
11158030
20.

Autoimmune Addison's disease--evidence for a role of steroid 21-hydroxylase autoantibodies in adrenal insufficiency.

Furmaniak J, Kominami S, Asawa T, Wedlock N, Colls J, Smith BR.

J Clin Endocrinol Metab. 1994 Nov;79(5):1517-21.

PMID:
7962352

Supplemental Content

Support Center